Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

Clinical trial NCT07278479 · RECRUITING

Trial details

NCT number: NCT07278479
Sponsor: Molecular Partners AG
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Large Cell Neuroendocrine Carcinoma Large Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC)Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Small Cell Lung Cancer (SCLC)Gastroenteropancreatic NEC (GEP NEC)NEC of the Bladder Other DLL3 Expressing epNEC

Start date: 2026-05-18
Primary completion: 2028-09-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.